EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)

A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post‐Cataract Surgery Inflammation

Yuanyuan Zhao, Keer Chen iD, Jun Zhou, Jun Zhao, Dingheng Zhang, Junyue Wan, Weihong Yuan, Xi Chen, Ming Tan, Fuqiang Cui, Shein-Chung Chow, Ying Wu iD

Clinical Pharmacology & Therapeutics · 2025

DOI: 10.1002/cpt.70010 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Yuanyuan Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hainan University, Haikou, Hainan, China. Hauptthemen laut MEDLINE: Dexamethasone, Inflammation, Anti-Inflammatory Agents, Glucocorticoids. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangzhou Basic and Applied Basic Research Foundation, Hainan Institute of Real World Data.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional randomized controlled trials (RCTs) face increasing challenges due to lengthy recruitment and high costs. Regulators have encouraged the use of external data and real‐world evidence (RWE) to improve efficiency, yet adoption in confirmatory settings remains limited by concerns over heterogeneity and bias. We conducted a proof‐of‐concept study to assess the feasibility and regulatory value of a hybrid Bayesian borrowing design to support a Phase III RCT of Dexamethasone Intracameral Drug‐Delivery Suspension (DEXYCU) in China. Using the Equivalence Probability Propensity Score Meta‐Analytic‐Predictive (EQPSMAP) approach, we integrated three data sources—a global RCT, a regional Phase III RCT in China, and a real‐world data (RWD) in China. The method’s performance was evaluated via point estimates and 95% credible intervals for the primary efficacy endpoint. The hybrid design based on EQPSMAP demonstrated greater robustness and accuracy in the presence of baseline imbalances and heterogeneous data. Compared to a traditional RCT, the hybrid design reduced the required sample size by 41 to 158 patients and shortened trial duration by approximately 2 to 5 months while preserving internal validity. This study demonstrated the feasibility and regulatory value of hybrid Bayesian designs in late‐phase trials. The approach offers a practical, bias‐controlled framework for integrating external data into regional drug development and regulatory decision making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneInflammationAnti-Inflammatory AgentsGlucocorticoidsHumansBayes TheoremMaleResearch DesignFemaleChinaAgedProof of Concept StudyMiddle AgedSuspensionsFeasibility StudiesDrug Delivery SystemsRandomized Controlled Trials as Topic

Substanzen

DexamethasoneAnti-Inflammatory AgentsSuspensionsGlucocorticoids

Autor:innen und Institutionen

  • Hainan University, Haikou, Hainan, China.
  • Hainan Lecheng Institute of Real World Study, Qionghai, Hainan, China.
  • Department of Biostatistics, Southern Medical University, Guangzhou, Guangdong, China.
  • Center for Drug Evaluation, National Medical Products Administration, Beijing, China.
  • Health Science Center, Peking Universtiy, Beijing, China.
  • China Center for Food and Drug International Exchange, Beijing, China.

ORCID-Profile: Keer Chen, Ying Wu

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Basic and Applied Basic Research Foundation
  • Hainan Institute of Real World Data

Zitieren

APA

Zhao, Y., Chen, K., Zhou, J., Zhao, J., Zhang, D., Wan, J., Yuan, W., Chen, X., Tan, M., Cui, F., Chow, S. C., & Wu, Y. (2025). A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post‐Cataract Surgery Inflammation. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70010

Vancouver

Zhao Y, Chen K, Zhou J, Zhao J, Zhang D, Wan J, et al. A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post‐Cataract Surgery Inflammation. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.70010

BibTeX
@article{Zhao2025,
  author = {Zhao, Yuanyuan and Chen, Keer and Zhou, Jun and Zhao, Jun and Zhang, Dingheng and Wan, Junyue and Yuan, Weihong and Chen, Xi and Tan, Ming and Cui, Fuqiang and Chow, Shein-Chung and Wu, Ying},
  title = {A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post‐Cataract Surgery Inflammation},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1002/cpt.70010}
}
Kostenlos starten →